Business description: Pfizer Inc

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:

- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;

- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;

- oncology products (12.1%);

- other (1.3%).

At the end of 2022, the group had more than 35 manufacturing sites worldwide.

Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).

Sales by Activity: Pfizer Inc

Fiscal Period: December20192020202120222023

Global Biopharmaceuticals Business (Biopharma)

39.42B 41.91B 79.56B 98.99B 57.19B

Upjohn

10.23B - - - -

Other business activities

2.1B - 1.73B 1.34B 1.31B
See all business segments

Geographical breakdown of sales: Pfizer Inc

Fiscal Period: December20192020202120222023

United States

23.85B 21.71B 29.75B 42.47B 27.09B

Emerging Markets

12.73B 8.37B 20.7B 20.1B 12B

Developed Europe

8.7B 7.79B 18.34B 21.98B 11.65B

International

6.46B 4.04B 12.51B 15.78B 7.76B
See all geographic segments

Managers: Pfizer Inc

Director TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Compliance Officer 63 93-12-31
Chief Tech/Sci/R&D Officer - 20-12-31
Chief Tech/Sci/R&D Officer 60 22-08-31
See PFIZER INC governance

Members of the board: Pfizer Inc

Manager TitleAgeSince
Director/Board Member 66 07-08-31
Director/Board Member 71 11-12-11
Director/Board Member 60 13-09-26
Chief Executive Officer 62 92-12-31
Director/Board Member 64 14-06-25
Director/Board Member 66 15-06-24
Director/Board Member 64 17-02-22
Director/Board Member 71 18-03-04
Director/Board Member 51 19-06-26
Director/Board Member 59 20-02-26
Composition of the Board of Directors

Shareholders: Pfizer Inc

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.025 %
511,403,040 9.025 % 14 836 M $
BlackRock Advisors LLC
5.625 %
318,759,774 5.625 % 9 247 M $
287,055,061 5.066 % 8 327 M $
Wellington Trust Co., NA
2.935 %
166,319,861 2.935 % 4 825 M $
Charles Schwab Investment Management, Inc.
2.070 %
117,279,599 2.070 % 3 402 M $
NameEquities%Valuation
Caixa DTVM SA
0.001465 %
332,002 0.001465 % 2 M $
Itaú Unibanco SA
0.001085 %
245,880 0.001085 % 2 M $
Bram Bradesco Asset Management S/A DTVM
0.000213 %
48,328 0.000213 % 345 694 $
XP Allocation Asset Management Ltda.
0.000026 %
5,790 0.000026 % 41 416 $
BTG Pactual WM Gestão de Recursos Ltda.
0.000013 %
2,999 0.000013 % 21 452 $
List of PFIZER INC shareholders

Holdings: Pfizer Inc

NameEquities%Valuation
2,955,063,62632.39%14,835,719,631 $
29,243,04263.92%2,113,839,140 $
3,457,8155.04%90,456,440 $
2,525,2523.64%68,686,854 $
22,032,04010.54%57,944,265 $
9,549,7616.86%34,777,365 $
7,032,77011.93%26,654,198 $
115,928,8039.03%23,036,212 $
1,272,2144.96%21,436,806 $
1,885,1362.10%18,125,677 $

Company details: Pfizer Inc

Pfizer Inc.

66 Hudson Boulevard East

10001-2192, New York

+212 733 2323

http://www.pfizer.com
address Pfizer Inc

Group companies: Pfizer Inc

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
Medical Distributors
Pfizer Overseas LLC
Pfizer Luxembourg SARL
See all subsidiaries

Other Pharmaceuticals

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.21%+2.33%+60.46%+295.20%832B
+0.47%+4.20%+37.81%+188.65%605B
+0.53%+0.69%+2.52%+0.06%398B
+0.10%+0.42%+27.67%+80.21%343B
+0.53%-1.68%+7.76%+59.13%294B
+0.99%-3.14%+1.63%-22.72%252B
-1.01%-5.71%+9.03%+46.81%243B
-0.28%-0.45%+6.39%+25.44%234B
+0.72%+3.71%+27.51%+52.41%179B
Average +0.09%+0.04%+20.09%+80.58% 375.56B
Weighted average by Cap. -0.08%+0.82%+28.09%+125.90%
See all sector performances
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW